Skip to main content
. 2021 Nov 18;11:768993. doi: 10.3389/fcimb.2021.768993

Table 1.

Clinical characteristics and laboratory findings of the SARS and Control groups in 2018.

SARS n = 53 Control n = 45 P value
Male sex (%) 8 (15.09%) 10 (22.22%) 0.364
Age (years) 46 (40-51) 44 (40-48) 0.337
Comorbidities, n (%)
Heart disfunction 1 (2.0%) 1 (2.4%) 1.000
Chronic renal disease 0 (0.0%) 0 (0.0%)
Liver disease 0 (0.0%) 0 (0.0%)
Diabetes mellitus 2 (4.1%) 2 (4.8%) 1.000
High pressure 6 (12.2%) 5 (11.9%) 0.960
Pulmonary fibrosis 18 (36.7%) 0 (0.0%) <0.0001
Laboratory findings
White blood cell (×103/mm3) 5.72 ± 0.24 5.89 ± 0.21 0.614
Neutrophils(×103/mm3) 3.19 ± 0.16 3.26 ± 0.15 0.740
Lymphocytes(×103/mm3) 1.74 (1.41-2.34) 1.93 (1.68-2.28) 0.420
Hemoglobin level (g/dL) 135.36 ± 2.00 138.73 ± 2.30 0.269
Platelet count (×103/mm3) 269.00 (230.50-309.50) 252.00 (234.00-293.50) 0.408
Glucose (mmol/L) 5.09 (4.78-5.41) 5.21 (4.81-5.64) 0.0.32
Albumin (g/L) 44.28 ± 0.32 45.36 ± 0.36 0.073
ALT (U/L) 17.00 (12.00-21.50) 17.00 (13.00-23.00) 0.892
AST (U/L) 18.00 (16.00-24.00) 18.00 (16.00-21.00) 0.429
LDH (U/L) 159.13 ± 3.34 165.84 ± 4.00 0.197
CREA (µmol/L) 56.00 (52.00-56.50) 54.00 (47.00-64.00) 0.175
IgA (g/L) 2.05 (1.69-3.05) 2.17 (1.56-2.54) 0.503
IgG (g/L) 12.30(10.90-13.45) 13.00 (11.20-14.65) 0.059
IgM (g/L) 0.95 (0.71-1.15) 1.09 (0.76-1.37) 0.163
C3 (g/L) 0.92 ± 0.02 0.95 ± 0.03 0.417

SARS group: convalescents who were infected with SARS-CoV in 2003; Control group: close contacts of SARS group who were not infected with SARS-CoV in 2003. Data are presented as means ± standard error from the mean, or median (interquartile range) or n (%). ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; LDH, lactate dehydrogenase; CREA, Creatinine; IgA, immunoglobin A; IgG, immunoglobin G; IgM, immunoglobin M; C3, complement C3.

The bold value mean that P value < 0.05 and were statistically significant.